Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023April 30, 2024 ASX-listed Bioxyne has released its first annual report since it acquired Breathe Life Sciences (BLS) in […]
Bioxyne inks JV to launch AI-powered B2B platform in Australia by Martin Lane August 21, 2023April 30, 2024
ASX-listed Bioxyne launches telehealth platform BLS Clinics by Martin Lane June 21, 2023April 30, 2024
